Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Segmental Revision System

NCT03270982 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03270982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Segmental Revision System
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 2016
Completion date
December 31, 2035
Enrollment
105 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disease, oncology, revision surgery, rheumatoid arthritis, trauma